What is Trig/HDL-C (Triglyceride to HDL Cholesterol Ratio)?

The Trig/HDL-C ratio divides your triglyceride level by your HDL cholesterol level to assess metabolic health and cardiovascular risk. A ratio below 2.0 is ideal, while ratios above 3.5 indicate increased risk for heart disease and insulin resistance.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Trig/HDL-C Ratio

The triglyceride to HDL cholesterol ratio (Trig/HDL-C) is a simple yet powerful calculation that provides insight into your metabolic health and cardiovascular risk. This ratio is calculated by dividing your triglyceride level by your HDL (high-density lipoprotein) cholesterol level, both measured in mg/dL.

While individual cholesterol numbers matter, the relationship between triglycerides and HDL cholesterol tells a more complete story about your metabolic function. This ratio has emerged as one of the most reliable predictors of insulin resistance, metabolic syndrome, and cardiovascular disease risk, often outperforming traditional cholesterol measurements alone.

Understanding your Trig/HDL-C ratio can help you identify metabolic issues before they progress to more serious conditions. Regular monitoring of this biomarker provides valuable feedback on how your lifestyle choices impact your health.

Trig/HDL-C Ratio Risk Categories

Ratios calculated using triglycerides and HDL-C measured in mg/dL from fasting blood samples.
Ratio RangeRisk CategoryHealth ImplicationsRecommended Actions
Below 1.0< 1.0OptimalExcellent metabolic health, very low cardiovascular riskMaintain current lifestyle habits
1.0-2.01.0-2.0IdealGood metabolic health, low cardiovascular riskContinue healthy habits, monitor annually
2.0-3.52.0-3.5Moderate RiskEarly insulin resistance possible, increased cardiovascular riskImplement lifestyle changes, test every 6 months
Above 3.5> 3.5High RiskSignificant insulin resistance, high cardiovascular riskAggressive lifestyle intervention, consider medical evaluation

Ratios calculated using triglycerides and HDL-C measured in mg/dL from fasting blood samples.

Why the Trig/HDL-C Ratio Matters

The Trig/HDL-C ratio serves as a window into your body's metabolic processes. When functioning optimally, your body maintains low triglyceride levels while producing adequate amounts of protective HDL cholesterol. However, when metabolic dysfunction occurs, triglycerides tend to rise while HDL levels drop, creating an unfavorable ratio.

Research has consistently shown that the Trig/HDL-C ratio correlates strongly with insulin resistance, a condition where cells become less responsive to insulin's signals. This resistance forces the pancreas to produce more insulin, leading to a cascade of metabolic problems including weight gain, inflammation, and increased cardiovascular risk.

The ratio also reflects the size and density of LDL particles in your blood. A high Trig/HDL-C ratio typically indicates a predominance of small, dense LDL particles, which are more likely to penetrate arterial walls and contribute to plaque formation compared to larger, fluffier LDL particles.

Optimal Trig/HDL-C Ratio Ranges

Understanding where your ratio falls on the risk spectrum helps guide health decisions and interventions. Here are the generally accepted ranges for the Trig/HDL-C ratio:

These ranges apply to measurements taken in mg/dL. If your lab uses mmol/L, the ratio thresholds remain the same, but the individual values will differ. It's worth noting that optimal ranges may vary slightly based on ethnicity, with some populations showing different risk profiles at similar ratio levels.

For the most accurate assessment, your Trig/HDL-C ratio should be calculated from a fasting blood test, as triglyceride levels can fluctuate significantly after meals. Most experts recommend testing after a 12-hour fast for the most reliable results.

Gender Differences in Trig/HDL-C Ratios

Men and women often show different patterns in their lipid profiles. Women typically have higher HDL cholesterol levels than men, particularly before menopause, which can result in more favorable ratios. However, after menopause, women's triglyceride levels tend to rise while HDL levels may decline, potentially worsening their ratio.

These gender differences underscore the importance of personalized health monitoring and interpretation of results within the context of your individual health profile, age, and hormonal status.

Factors That Affect Your Trig/HDL-C Ratio

Multiple factors influence your triglyceride and HDL levels, ultimately affecting your ratio. Understanding these factors empowers you to make targeted improvements to your metabolic health.

Dietary Influences

Your diet plays a crucial role in determining your Trig/HDL-C ratio. High consumption of refined carbohydrates and added sugars directly increases triglyceride production in the liver. Conversely, healthy fats from sources like olive oil, avocados, and fatty fish can help raise HDL levels while potentially lowering triglycerides.

Alcohol consumption has a complex relationship with this ratio. Moderate alcohol intake may slightly increase HDL levels, but excessive consumption significantly raises triglycerides, ultimately worsening the ratio. The type and pattern of alcohol consumption also matter, with binge drinking being particularly harmful to lipid profiles.

Lifestyle and Physical Activity

Regular physical activity is one of the most effective ways to improve your Trig/HDL-C ratio. Exercise helps lower triglycerides by improving insulin sensitivity and increasing the muscles' ability to use fat for fuel. It also stimulates the production of enzymes that help raise HDL cholesterol levels.

Sleep quality and stress management also significantly impact your ratio. Chronic sleep deprivation and high stress levels can increase triglyceride production while suppressing HDL levels. Both conditions promote insulin resistance, creating a metabolic environment that worsens your ratio over time.

Medical Conditions and Medications

Several medical conditions can adversely affect your Trig/HDL-C ratio. Type 2 diabetes and prediabetes are strongly associated with high triglycerides and low HDL levels. Hypothyroidism, polycystic ovary syndrome (PCOS), and metabolic syndrome also commonly present with unfavorable ratios.

Certain medications can influence your ratio as well. Beta-blockers, thiazide diuretics, and some antipsychotic medications may raise triglycerides or lower HDL levels. Conversely, statins, fibrates, and niacin can help improve the ratio, though their effects vary among individuals.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Health Implications of Your Trig/HDL-C Ratio

The Trig/HDL-C ratio provides valuable insights into multiple aspects of your health beyond just cardiovascular risk. A high ratio often indicates underlying metabolic dysfunction that can affect various body systems.

Cardiovascular Disease Risk

Studies have shown that the Trig/HDL-C ratio is a strong independent predictor of cardiovascular events, including heart attacks and strokes. A ratio above 3.5 is associated with a significantly increased risk of coronary artery disease, even in individuals with normal LDL cholesterol levels.

The ratio also predicts the progression of atherosclerosis more accurately than traditional cholesterol measurements alone. This is because it reflects not just the quantity of cholesterol particles but also their quality and the overall metabolic environment in which they exist.

Metabolic Health and Insulin Resistance

The Trig/HDL-C ratio serves as a reliable marker of insulin resistance, often identifying metabolic dysfunction years before glucose levels become abnormal. A ratio above 3.0 suggests significant insulin resistance, while ratios above 4.0 indicate severe metabolic dysfunction that requires immediate attention.

This early warning system is particularly valuable because insulin resistance is reversible in its early stages through lifestyle modifications. By monitoring your ratio, you can track the effectiveness of interventions and make adjustments before progressing to prediabetes or type 2 diabetes.

How to Improve Your Trig/HDL-C Ratio

Improving your Trig/HDL-C ratio requires a comprehensive approach that addresses both triglyceride reduction and HDL enhancement. The good news is that this ratio responds well to lifestyle interventions, often showing improvement within weeks to months of implementing changes.

Dietary Strategies

Focus on reducing refined carbohydrates and added sugars, which are the primary dietary drivers of elevated triglycerides. Replace these with whole grains, vegetables, and legumes that provide fiber and nutrients while minimizing blood sugar spikes. Increasing your intake of omega-3 fatty acids from fish, walnuts, and flaxseeds can help lower triglycerides while supporting HDL production.

  • Limit added sugars to less than 25 grams per day
  • Choose whole grains over refined grains
  • Include fatty fish like salmon or sardines 2-3 times per week
  • Add nuts, seeds, and avocados for healthy fats
  • Increase soluble fiber from oats, beans, and vegetables

Exercise and Movement

Both aerobic exercise and resistance training can improve your Trig/HDL-C ratio, though they work through slightly different mechanisms. Aerobic exercise is particularly effective at lowering triglycerides, while resistance training helps improve insulin sensitivity and muscle glucose uptake.

Aim for at least 150 minutes of moderate-intensity exercise per week, or 75 minutes of vigorous exercise. High-intensity interval training (HIIT) has shown particular promise for improving lipid profiles quickly. Even simple activities like brisk walking after meals can help blunt triglyceride spikes and improve your overall ratio.

Weight Management and Body Composition

Excess body weight, particularly abdominal fat, strongly correlates with high triglycerides and low HDL levels. Even modest weight loss of 5-10% of body weight can significantly improve your Trig/HDL-C ratio. Focus on sustainable changes rather than extreme diets, as rapid weight loss can temporarily worsen triglyceride levels.

Building and maintaining muscle mass through resistance training is equally important. Muscle tissue is metabolically active and helps improve insulin sensitivity, contributing to better triglyceride clearance and HDL production over time.

Testing and Monitoring Your Trig/HDL-C Ratio

Regular testing is essential for understanding your baseline ratio and tracking improvements over time. Since both triglycerides and HDL can fluctuate based on recent meals, stress, and other factors, consistent testing conditions provide the most reliable results.

Most healthcare providers recommend annual lipid panels for adults, but if you have an elevated Trig/HDL-C ratio or are actively working to improve it, more frequent testing every 3-6 months can help you track progress and adjust your approach. Home testing options now make it easier to monitor your levels regularly without frequent clinic visits.

When reviewing your results, remember that a single test provides a snapshot in time. Trends over multiple tests offer more valuable information than any individual result. Keep a record of your ratios along with notes about your diet, exercise, stress levels, and any medications to identify patterns and optimize your approach.

Taking Action on Your Trig/HDL-C Ratio

The Trig/HDL-C ratio offers a powerful tool for assessing and improving your metabolic health. Unlike some biomarkers that require medical intervention to change, this ratio responds remarkably well to lifestyle modifications. By understanding what drives your ratio and implementing targeted strategies, you can significantly reduce your risk of cardiovascular disease and metabolic dysfunction.

Start by getting your baseline levels tested and calculating your current ratio. If it's above 2.0, begin implementing the dietary and lifestyle changes outlined above. Track your progress with regular testing and adjust your approach based on results. Remember that improving your Trig/HDL-C ratio is not just about reducing cardiovascular risk—it's about optimizing your overall metabolic health for better energy, mental clarity, and long-term vitality.

References

  1. McLaughlin, T., Reaven, G., Abbasi, F., et al. (2005). Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? American Journal of Cardiology, 96(3), 399-404.[PubMed][DOI]
  2. Gaziano, J. M., Hennekens, C. H., O'Donnell, C. J., et al. (1997). Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 96(8), 2520-2525.[PubMed][DOI]
  3. Salazar, M. R., Carbajal, H. A., Espeche, W. G., et al. (2012). Relation among the plasma triglyceride/high-density lipoprotein cholesterol ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. American Journal of Cardiology, 109(12), 1749-1753.[PubMed][DOI]
  4. Vega, G. L., Barlow, C. E., Grundy, S. M., et al. (2014). Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. Journal of Investigative Medicine, 62(2), 345-349.[PubMed][DOI]
  5. Pacifico, L., Bonci, E., Andreoli, G., et al. (2014). Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutrition, Metabolism and Cardiovascular Diseases, 24(7), 737-743.[PubMed][DOI]
  6. Giannini, C., Santoro, N., Caprio, S., et al. (2011). The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care, 34(8), 1869-1874.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Trig/HDL-C ratio at home?

You can test your Trig/HDL-C ratio at home with SiPhox Health's Heart & Metabolic Program, which includes both triglycerides and HDL cholesterol testing. The program provides lab-quality results with personalized insights to help you track and improve your ratio over time.

What is the ideal Trig/HDL-C ratio?

The ideal Trig/HDL-C ratio is below 2.0, with ratios under 1.0 being optimal. Ratios between 2.0-3.5 indicate moderate risk, while ratios above 3.5 suggest high risk for cardiovascular disease and insulin resistance. These ranges apply when both values are measured in mg/dL.

How quickly can I improve my Trig/HDL-C ratio?

With consistent lifestyle changes, you can see improvements in your Trig/HDL-C ratio within 4-8 weeks. Triglycerides typically respond faster to dietary changes, often dropping within 2-4 weeks, while HDL levels may take 6-12 weeks to show significant improvement through exercise and dietary modifications.

Can medications improve my Trig/HDL-C ratio?

Yes, several medications can improve your ratio. Statins primarily lower LDL but may modestly improve the ratio. Fibrates are particularly effective at lowering triglycerides and raising HDL. Niacin can significantly raise HDL levels. However, lifestyle changes should be the first approach, with medications considered when lifestyle modifications aren't sufficient.

Why is the Trig/HDL-C ratio better than looking at cholesterol alone?

The Trig/HDL-C ratio provides insight into insulin resistance and metabolic health that total cholesterol or LDL levels alone cannot reveal. It predicts cardiovascular risk more accurately because it reflects both the protective effects of HDL and the harmful effects of elevated triglycerides, while also indicating the size and density of LDL particles.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details